Gene Silencing Market Insights Highlighting Opportunities Supporting Growth To 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Gene Silencing Market Between 2026 And 2030?

The gene silencing market has experienced rapid expansion in recent years. It is forecast to grow from $6.69 billion in 2025 to $7.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. The historical growth can be attributed to advancements in molecular biology research, the discovery of RNA interference mechanisms, an increase in academic research funding, a rise in genetic disease studies, and augmented pharmaceutical R&D spending.

The gene silencing market is projected for significant expansion in the coming years, set to reach $12.1 billion by 2030 with a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this growth during the forecast period include the increasing number of gene therapy pipelines, a heightened demand for targeted therapeutics, the broadening scope of CRISPR applications, intensified clinical trial activity, and the innovation of next-generation gene editing tools. Key trends anticipated within the forecast period encompass the wider adoption of RNA interference technologies, greater utilization of CRISPR-based gene silencing, an expansion in therapeutic gene targeting strategies, an elevated focus on precision medicine applications, and a surge in investment directed towards genetic research.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

What Key Factors Are Affecting The Gene Silencing Market Demand?

An increasing occurrence of genetic disorders is anticipated to stimulate the expansion of the gene silencing market in the future. These disorders are defined as health issues resulting from irregularities in a person’s DNA. Their identification is becoming more frequent, driven by progress in diagnostic methods, greater public understanding, and wider availability of genetic screening. The increase in genetic disorders stems from parents having children at an older age, which raises the likelihood of transmitting genetic mutations to their descendants. Gene silencing presents a promising method for managing genetic disorders, achieved by specifically deactivating the expression of defective or pathogenic genes. As an illustration, data from August 2023, provided by Down Syndrome UK, a charity based in the UK, indicates that approximately 40,000 individuals in the UK are impacted by Down syndrome, with roughly 1 in every 800 newborns affected by the condition. Consequently, the growing frequency of genetic disorders is fueling the expansion of the gene silencing market.

How Is Segmentation Applied In The Gene Silencing Market Segment Analysis?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

What Emerging Trends Are Seen In The Gene Silencing Market?

Leading companies operating in the gene silencing market are focusing on developing innovative technologies, such as small interfering RNA (siRNA), to enhance the precision and efficacy of gene therapy. Small interfering RNA (siRNA) refers to a type of RNA molecule that plays a vital role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, thereby preventing the production of disease-causing proteins. For instance, in October 2024, Judo Bio Inc., a US-based biotechnology company, launched siRNA, a next-generation drug that utilizes small interfering RNA (siRNA) for gene silencing. Its unique features include proprietary delivery systems, such as lipid nanoparticles or conjugated ligands, which ensure efficient uptake by specific cells or tissues, along with AI-driven platforms that accelerate the identification of viable gene targets.

Who Are The Companies Participating In The Gene Silencing Market Environment?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Get The Full Gene Silencing Market Report:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

Which Region Leads The Gene Silencing Market In Terms Of Market Share?

North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gene Silencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

Browse Through More Reports Similar to the Global Gene Silencing Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795